“The SIA acquisition will provide us Yet another stage closer to achieving our ambition of becoming a worldwide segment leader and innovator in breast reconstruction with future FDA approvals, investment decision in pipeline and evidence technology,” explained Jan De Witte, president and CEO, Integra LifeSciences.We make no representations or w